Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jens Svare is active.

Publication


Featured researches published by Jens Svare.


British Journal of Obstetrics and Gynaecology | 2006

Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections

Jens Svare; H Schmidt; Bb Hansen; Gunnar Lose

Objective  To determine the prevalence of bacterial vaginosis (BV) in the second trimester of pregnancy in a Danish population using the Schmidt criteria and to examine whether BV was associated with subsequent preterm delivery, low birthweight or perinatal infections.


Acta Obstetricia et Gynecologica Scandinavica | 2004

Decreased fetal movements: background, assessment, and clinical management

Anette Olesen; Jens Svare

A reduction or cessation of fetal movements (FMs) is frequently reported by pregnant women and causes concern and anxiety. However, the clinical significance of a history of reduced FMs remains unclear, and the assessment and management of these pregnancies is controversial. This article is a review of the literature on decreased FMs found in medline and the cochrane library using the search phrases: decreased FMs, perinatal outcome, FM monitoring, and fetal assessment. Formal counting of FMs by the pregnant woman could possibly identify the fetuses, which are at risk of compromise, thus allowing for appropriate action. However, the benefit of this intervention has not been definitely proven. Cardiotocography, umbilical/uterine artery Doppler velocimetry, and ultrasonography have been used for antepartum fetal assessment in pregnancies with decreased FMs, but the evidence of a clinical benefit is limited. The effects of fetal assessment with vibroacoustic stimulation and biophysical profile are unknown and should be further evaluated. Present recommendations on the management of pregnancies with decreased FMs are based on limited and inconsistent scientific evidence. There is a need for further well‐designed studies in order to provide evidence‐based guidelines in the future.


Acta Obstetricia et Gynecologica Scandinavica | 2001

Perinatal complications in women with gestational diabetes mellitus

Jens Svare; Bent Brandt Hansen; Lars Mølsted-Pedersen

Background. The aim of the study was to examine the outcome of the pregnancy and neonatal period in 1) women with gestational diabetes mellitus and non‐diabetic pregnant women, and 2) in women with early and late diagnosis of gestational diabetes mellitus.


British Journal of Obstetrics and Gynaecology | 1997

Ampicillin‐metronidazole treatment in idiopathic preterm labour: a randomised controlled multicentre trial

Jens Svare; Jens Langhoff-Roos; Lars Franch Andersen; NieIs Kryger‐Baggesen; Hanne Borch-Christensen; Lars Heisterberg; Jens Kristensen

Objective To determine whether treatment with ampicillin and metronidazole in women with threatened idiopathic preterm labour will prolong the gestation and reduce maternal and neonatal infectious morbidity.


Trials | 2012

The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial

Anne Wikkelsøe; Arash Afshari; Jakob Stensballe; Jens Langhoff-Roos; Charlotte Krebs Albrechtsen; Kim Ekelund; Gabriele Hanke; Heidi Sharif; Anja U. Mitchell; Jens Svare; Ane Troelstrup; Lars Pedersen; Jeannet Lauenborg; Mette Gøttge Madsen; Birgit Bødker; Ann Merete Møller

BackgroundPostpartum haemorrhage (PPH) remains a leading cause of maternal mortality worldwide. In Denmark 2% of parturients receive blood transfusion. During the course of bleeding fibrinogen (coagulation factor I) may be depleted and fall to critically low levels, impairing haemostasis and thus worsening the ongoing bleeding. A plasma level of fibrinogen below 2 g/L in the early phase of postpartum haemorrhage is associated with subsequent development of severe haemorrhage. Use of fibrinogen concentrate allows high-dose substitution without the need for blood type crossmatch. So far no publications of randomised controlled trials involving acutely bleeding patients in the obstetrical setting have been published. This trial aims to investigate if early treatment with fibrinogen concentrate reduces the need for blood transfusion in women suffering severe PPH.Methods/DesignIn this randomised placebo-controlled double-blind multicentre trial, parturients with primary PPH are eligible following vaginal delivery in case of: manual removal of placenta (blood loss ≥ 500 ml) or manual exploration of the uterus after the birth of placenta (blood loss ≥ 1000 ml). Caesarean sections are also eligible in case of perioperative blood loss ≥ 1000 ml. The exclusion criteria are known inherited haemostatic deficiencies, prepartum treatment with antithrombotics, pre-pregnancy weight <45 kg or refusal to receive blood transfusion. Following informed consent, patients are randomly allocated to either early treatment with 2 g fibrinogen concentrate or 100 ml isotonic saline (placebo). Haemostatic monitoring with standard laboratory coagulation tests and thromboelastography (TEG, functional fibrinogen and Rapid TEG) is performed during the initial 24 hours.Primary outcome is the need for blood transfusion. To investigate a 33% reduction in the need for blood transfusion, a total of 245 patients will be included. Four university-affiliated public tertiary care hospitals will include patients during a two-year period. Adverse events including thrombosis are assessed in accordance with International Conference on Harmonisation (ICH) good clinical practice (GCP).DiscussionA widespread belief in the benefits of early fibrinogen substitution in cases of PPH has led to increased off-label use. The FIB-PPH trial is investigator-initiated and aims to provide an evidence-based platform for the recommendations of the early use of fibrinogen concentrate in PPH.Trial registrationClincialTrials.gov NCT01359878.


Neurourology and Urodynamics | 2012

Urinary incontinence during pregnancy and 1 year after delivery in primiparous women compared with a control group of nulliparous women

Bent Brandt Hansen; Jens Svare; Lars Viktrup; Torben Jørgensen; Gunnar Lose

To investigate the impact of the first pregnancy and delivery on the prevalence and types of urinary incontinence during pregnancy and 1 year after delivery.


European Journal of Obstetrics & Gynecology and Reproductive Biology | 1992

The relationship between prior cervical conization, cervical microbial colonization and preterm premature rupture of the membranes.

Jens Svare; Lars Franch Andersen; Jens Langhoff-Roos; Elsebeth Tvenstrup Jensen; Brita Bruun; Inga Lind; Hans O. Madsen

The occurrence of prior cervical conization and the cervical microbial colonization was investigated in 38 women with idiopathic preterm labor, 35 women with preterm premature rupture of the membranes (PPROM) and 75 normal pregnant women at 26-34 weeks of gestation. Data were analyzed by Fishers exact test (two-tailed). The frequency of prior cervical conization was significantly higher in PPROM patients compared to normal pregnant women (P < 0.001) and to patients in preterm labor (P < 0.01). Lactobacilli occurred with a lower frequency in patients with PPROM compared to patients in preterm labor (P < 0.05) and control patients (P = 0.0543)-and with a lower frequency in patients with prior cervical conization (P < 0.05). All other microorganisms occurred with the same frequencies in all groups. The absence of lactobacilli may indicate changes in the cervical flora, which could increase the risk of PPROM. Prior cervical conization may impair the antimicrobial defense-mechanisms in the cervix, which could facilitate ascending microbial colonization. This may lead to a release of prostaglandins and proteolytic enzymes and subsequently preterm labor and rupture of the membranes.


Acta Obstetricia et Gynecologica Scandinavica | 2016

Treatment of bacterial vaginosis in pregnancy in order to reduce the risk of spontaneous preterm delivery: a clinical recommendation

Thor Haahr; Anne S Ersbøll; Mona Aarenstrup Karlsen; Jens Svare; Kirstine Sneider; Lene Hee; Louise Katrine Kjær Weile; Agnes Ziobrowska-Bech; Claus Østergaard; Jørgen Skov Jensen; Rikke Bek Helmig; Niels Uldbjerg

Bacterial vaginosis (BV) is characterized by a dysbiosis of the vaginal microbiota with a depletion of Lactobacillus spp. In pregnancy, prevalences between 7 and 30% have been reported depending on the study population and the definition. BV may be associated with an increased risk of spontaneous preterm delivery (sPTD). However, it is controversial whether or not BV‐positive pregnant women will benefit from treatment to reduce the risk of sPTD. We could not identify any good‐quality guideline addressing this issue. Consequently we aimed to produce this clinical recommendation based on GRADE.


Diabetes, Obesity and Metabolism | 2013

Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus

Lisbeth Bonde; Tina Vilsbøll; Trine Nielsen; Jonatan I. Bagger; Jens Svare; Jens J. Holst; Steen Larsen; Filip K. Knop

We investigated postprandial glucagon‐like peptide‐1 (GLP‐1) responses in pregnant women with and without gestational diabetes mellitus (GDM) and again following delivery when normal glucose tolerance (NGT) was re‐established.


Gynecologic and Obstetric Investigation | 1991

Maternal-fetal listeriosis : 2 case reports

Jens Svare; Lars Franch Andersen; Jens Langhoff-Roos; Hans O. Madsen; Brita Bruun

Two cases of maternal-fetal infection with Listeria monocytogenes are reported. Both women were admitted with influenza-like symptoms and preterm labor at 32 and 34 weeks of gestation, respectively. The infants were delivered within a few days of onset of maternal symptoms. One infant was seriously ill with meningitis and subsequently developed hydrocephalus. The other infant suffered from septicemia, but had no sequelae. It is recommended always to consider the diagnosis listeriosis in pregnant women with fever of unknown origin and preterm labor.

Collaboration


Dive into the Jens Svare's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hans O. Madsen

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar

Gunnar Lose

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar

Brita Bruun

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Filip K. Knop

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar

Jens J. Holst

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar

Tina Vilsbøll

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar

Anne S Ersbøll

Copenhagen University Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge